Suchen Sie nach Informationen zu Unternehmenszentrale Von Biogen Idec Inc? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
Biogen is committed to the power of diversity – in our organization and among our patients and customers. Diversity is an essential asset of complementary strengths and perspectives from which all benefit, and which must unite us, not divide us. Learn more about our commitment.
https://www.company-histories.com/Biogen-Idec-Inc-Company-History.html
Biogen Idec Inc., formed through the 2003 merger of Biogen Inc. and IDEC Pharmaceuticals Corporation (Idec), is a biotechnology company focused on developing treatments for cancer and autoimmune and inflammatory diseases. The company's portfolio of approved drugs includes Rituxan and Zevalin, both of which treat B-cell non-Hodgkin's lymphoma.
https://investors.biogen.com/news-releases/news-release-details/biogen-idec-becomes-biogen
Biogen Idec Becomes Biogen. March 23, 2015 • Corporate. New Corporate Identity and Brand Reflect Company’s Heritage and Commitment to Patients and Science. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its evolution and …
https://www.fda.gov/about-fda/ora-foia-electronic-reading-room/biogen-idec-inc
Biogen Idec Inc., RTP, NC, 483 Issued 8/2/2013; Content current as of: 12/06/2013. Topic(s) Freedom of Information (FOI) ORA FOIA Electronic Reading Room Footer Links. FDA Archive ...
https://investors.biogen.com/investor-relations
Biogen | Investor Relations
https://rocketreach.co/biogen-idec-profile_b5c616abf42e0c4c
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved …
https://www.denodo.com/de/kunde/biogen-idec
Biogen is a global biotechnology company, founded in 1978, with over $4B in revenue. Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis.
https://www.pharmaceutical-technology.com/projects/biogen/
The contract was worth SEK191m. Biogen Idec, the world’s third largest biotech company believed that it needed to have new Danish head offices near to its new large-scale manufacturing facility. The contract was for the construction of three buildings that contain laboratory, administrative and restaurant facilities.
https://enciclopediaencarta.com/biogen-idec-inc/
Teléfono: (617) 679-2000. Biogen Idec Inc., formada a través de la fusión en 2003 de Biogen Inc. e IDEC Pharmaceuticals Corporation (Idec), es una empresa de biotecnología centrada en el desarrollo de tratamientos para el cáncer y las enfermedades autoinmunes e inflamatorias. La cartera de medicamentos aprobados de la compañía incluye ...
https://www.zoominfo.com/c/biogen/33791530
Founded in 1978, Biogen Idec is a biotechnology company specializing in treatments in the areas of immunology and neurology. The company's name-brand drugs incl ude Avonex (for multiple sclerosis), Tysabri (for multiple sclerosis and Crohn's disease), Rituxan (developed jointly with Genentech for the treatment of non-Hodgkin's lymphoma and …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Unternehmenszentrale Von Biogen Idec Inc gefunden haben.
